BioSpace - Axonyx Inc. News, Search Jobs, Events
Company Profile. Axonyx Inc. 750 Lexington Avenue Suite 1400 New York New York 10022 U.S.A. Phone: 212-688-4770 Fax: 212-688-4843 SEARCH JOBS. Industry ...
http://www.biospace.com/company_profile.aspx?CompanyId=83604...
|
News: Axonyx and TorreyPines Therapeutics Announce Merger ...
8 Jun 2006 ... Axonyx and TorreyPines Therapeutics Announce Merger Agreement; Transaction Creates Robust Portfolio in the CNS Disease Area.
http://www.genengnews.com/news/bnitem.aspx?name=2306584...
|
BioPortfolio - Axonyx
Axonyx - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/1148-Axonyx.html...
|
Phenserine Axonyx Urmila Thatte
In February 1997, Axonyx acquired exclusive rights to a series of AChE and BChE inhibitors, including phenserine, from the ...
http://www.biomedcentral.com/content/pdf/cd-608240.pdf...
|
BioPortfolio - Axonyx Inc.
15 Nov 2008 ... Axonyx Inc. - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/19038-Axonyx_Inc..h...
|
TorreyPines Therapeutics Completes Merger With Axonyx
In connection with the merger, Axonyx effected a 1-for-8 reverse stock split of its common stock. As a result of the merger and the reverse stock split, ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
BioPortfolio - Axonyx Incorporated
Axonyx Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/1149-Axonyx_Incorpo...
|
Phenserine Axonyx.
In March 2005, Axonyx suspended patient recruitment for the ongoing phase III trials of phenserine, after the drug failed to meet the primary endpoints of ...
http://www.ncbi.nlm.nih.gov/pubmed/16044670...
|
Axonyx and TorreyPines to merge
6th June 2006: TorreyPines Therapeutics and Axonyx have entered into a definitive merger agreement that will create a biopharmaceutical company focused
on ...
http://www.bioportfolio.com/biotech_news/Datamonitor_15.htm...
|
Axonyx Inc. Abandons Development Of Phenserine - News, Search Jobs ...
Axonyx has now evaluated its entire Phenserine development program, including the results from the first Phase III trial announced in February and March ...
http://www.biospace.com/news_story.aspx?NewsEntityId=2083...
|
